Regarding: "The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial".

Nakata, Takeshi; Ariie, Takashi; Taito, Shunsuke

Nakata, Takeshi; Ariie, Takashi; Taito, Shunsuke.

Nakata T; Department of Endocrinology Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi Yufu, Oita, 879-5593, Japan. nakata@oita-u.ac.jp.
Ariie T; Systematic Review Workshop Peer Support Group (SRWS-PSG), Osaka, Japan. nakata@oita-u.ac.jp.
Taito S; Department of Physical Therapy, School of Health Sciences at Fukuoka, International University of Health and Welfare, 137-1 Enokizu, Okawa-shi, Fukuoka, 831-8501, Japan.

J Transl Med ; 19(1): 282, 2021 06 30.

Article in English | MEDLINE | ID: covidwho-1286826

Subject(s)

COVID-19; Fatty Acids, Omega-3; Critical Illness; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fatty Acids, Omega-3 / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Traditional medicine Limits: Humans Language: English Journal: J Transl Med Year: 2021 Document Type: Article Affiliation country: S12967-021-02958-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google